Catherine Bollard, MD, associate center director for translational research and innovation at GW Cancer Center, was quoted by Interesting Engineering in an article about her recent study looking at the safety of a cell therapy involving expanding T-cells against HIV.
Interesting Engineering - First Ever HIV Immunotherapy Drug Proven Safe For Use in Humans
Latest News
The George Washington University School of Medicine and Health Sciences (GW SMHS) welcomed the MD Class of 2029 at the 27th Annual White Coat and Honor Code Ceremony, marking the first class of the school’s third century. The ceremony marked a public commitment to the profession and the beginning…
The Global Clinical Care Alliance (GCCA) at the George Washington University (GW) School of Medicine and Health Sciences (SMHS) announced the inaugural recipients of the GW Global Health Legacy Fellowship.
As fall begins and school resumes, the GW Cancer Center extends vital support to patients who are also parents. Led by Access Team Lead Janelle Williams, the center offers compassionate programs like school supply drives to ease the burden on families affected by cancer.